1. Anti-IFNAR treatment does not reverse neuropsychiatric disease in MRL/lpr lupus mice. (November 2019) Authors: Huang, M W; Stock, A D; Mike, E V; Herlitz, L; Kolbeck, R; Putterman, C Journal: Lupus Issue: Volume 28:Number 13(2019) Page Start: 1510 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Natural killer cell expression of Ki67 is associated with elevated serum IL-15, disease activity and nephritis in systemic lupus erythematosus. (19th March 2019) Authors: Hudspeth, K; Wang, S; Wang, J; Rahman, S; Smith, M A; Casey, K A; Manna, Z; Sanjuan, M; Kolbeck, R; Hasni, S; Ettinger, R; Siegel, R M Journal: Clinical and experimental immunology Issue: Volume 196:Number 2(2019) Page Start: 226 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OP0331 A novel humanized effector-deficient fcyriia antibody inhibits immune complex mediated proinflammatory responses. (15th June 2017) Authors: Chen, B; Vousden, K; Turman, S; Sun, H; Wang, S; Vinall, L; Kemp, B; Kasturiangan, S; Grant, E; Hinrichs, MJ; Eck, S; DiGiandomenico, A; Xiong, X; Griffiths, J; Herbst, R; Close, D; Kolbeck, R; Sims, G Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗